Rituximab plus CHOP for diffuse large-B-cell lymphoma.

The New England journal of medicine ·Vol. 346 ·No. 23 ·2002-06-06 ·Pages 1830-1; author reply 1830-1

Akhtar S, Maghfoor I

Abstract

暂无摘要

MeSH Terms

Antibodies, Monoclonal/therapeutic use Antibodies, Monoclonal, Murine-Derived Antineoplastic Combined Chemotherapy Protocols/administration & dosage Cyclophosphamide/administration & dosage Doxorubicin/administration & dosage Humans Lymphoma, B-Cell/drug therapy Lymphoma, Large B-Cell, Diffuse/drug therapy Prednisone/administration & dosage Rituximab Vincristine/administration & dosage

Chemicals

Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Rituximab Vincristine Doxorubicin Cyclophosphamide Prednisone

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Akhtar Saad

Maghfoor Irfan

Supplementary Concepts

CHOP protocol (Protocol)

Article Info

Journal

The New England journal of medicine

Abbr.

N Engl J Med

ISSN

1533-4406

DOI

10.1056/NEJM200206063462317

Published

2002-06-06

Pages

1830-1; author reply 1830-1

Language

English

Region

United States

NLM ID

0255562

Subset

Corrections

CommentOn

PMID: 11807147

External Links

PubMed source DOI: 10.1056/NEJM200206063462317 View journal details

Analysis Services

Rituximab plus CHOP for diffuse large-B-cell lymphoma.

Contact

WeChat Official Account